中国医药导刊
中國醫藥導刊
중국의약도간
Chinese Journal of Medical Guide
2015年
9期
945-946
,共2页
冠心病不稳定型心绞痛%血塞通%疗效%炎症因子
冠心病不穩定型心絞痛%血塞通%療效%炎癥因子
관심병불은정형심교통%혈새통%료효%염증인자
Unstable angina pectoris%Xuesetong%Efficacy%Inflammatory cytokines
目的:探讨血塞通注射液对冠心病不稳定型心绞痛治疗的临床疗效及炎症因子的影响分析.方法:选择我院2011年8月至2014年2月收治的76例冠心病不稳定型心绞痛患者为研究对象,随机数字表法分为对照组38例,观察组38例,其中对照组实施基础治疗;观察组在对照组治疗基础上加用血塞通注射液辅助治疗,比较两组治疗结果.结果:观察组治疗总有效率为94.74%,对照组为78.95%,观察组疗效显著较对照组高(P<0.05).结论:冠心病不稳定型心绞痛在常规治疗基础上加用血塞通注射液,可以有效提高临床疗效,降低症状积分及炎症因子水平,控制病情发展,有利于患者早期恢复.
目的:探討血塞通註射液對冠心病不穩定型心絞痛治療的臨床療效及炎癥因子的影響分析.方法:選擇我院2011年8月至2014年2月收治的76例冠心病不穩定型心絞痛患者為研究對象,隨機數字錶法分為對照組38例,觀察組38例,其中對照組實施基礎治療;觀察組在對照組治療基礎上加用血塞通註射液輔助治療,比較兩組治療結果.結果:觀察組治療總有效率為94.74%,對照組為78.95%,觀察組療效顯著較對照組高(P<0.05).結論:冠心病不穩定型心絞痛在常規治療基礎上加用血塞通註射液,可以有效提高臨床療效,降低癥狀積分及炎癥因子水平,控製病情髮展,有利于患者早期恢複.
목적:탐토혈새통주사액대관심병불은정형심교통치료적림상료효급염증인자적영향분석.방법:선택아원2011년8월지2014년2월수치적76례관심병불은정형심교통환자위연구대상,수궤수자표법분위대조조38례,관찰조38례,기중대조조실시기출치료;관찰조재대조조치료기출상가용혈새통주사액보조치료,비교량조치료결과.결과:관찰조치료총유효솔위94.74%,대조조위78.95%,관찰조료효현저교대조조고(P<0.05).결론:관심병불은정형심교통재상규치료기출상가용혈새통주사액,가이유효제고림상료효,강저증상적분급염증인자수평,공제병정발전,유리우환자조기회복.
Objective: To investigate the clinical efficacy of Xuesetong injection adjuvant therapy in treating unstable angina pectoris and to analyze its effects in inflammatory cytokines.Methods:Selected 76 cases of patients with unstable angina pectoris from Aug 2011 to Feb 2014 and randomly divided them into observation(A) group and control(B) group,each with 38 cases. The B group was given basic treatment,and the A group was given assistant treatment of Xuesetong injection on the basis of B group. compare the two groups of treatment results.Results:The A group's total efficiency was 94.74% which was obviously higher than the B group,whose was 78.95%(P<0.05).Conclusion:In treating unstable angina pectoris,assisting Xuesetong injection on the basis of conventional treatment can effectively improve clinical efficacy, lower symptom score and inflammatory cytokines level,control disease development,which is good at patient's early recovery.